A clinical stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials. Through their diverse experience and extensive industry network, They are building Medicus into a leading pharmaceutical holding company, committed to delivering better treatment outcomes and alleviate pain and suffering. Utilizing a thesis driven collaborative process, they identify, acquire and advance relatively de-risked clinical stage assets through clinical development and commercialization.